ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,318Medicare Part D Prescriptions Filled, Including Refills

Rank: 177 out of 910

$497K Total Retail Price of All Prescriptions

Rank: 177 out of 910

519 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 519 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 519 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,623 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 476 448 1 2
SIMVASTATIN 411 384 2 3
HYDROCHLOROTHIAZIDE 394 375 3 12
LEVOTHYROXINE SODIUM 346 336 4 1
AMLODIPINE BESYLATE 307 306 5 4
HYDROCODONE-ACETAMINOPHEN 278 254 S3 6 8
LOSARTAN POTASSIUM 249 230 7 15
OMEPRAZOLE 199 176 8 5
ATENOLOL 175 171 9 10
POTASSIUM CHLORIDE 158 152 10 18
ZOLPIDEM TARTRATE 144 136 11 17
PRAVASTATIN SODIUM 135 130 12 16
WARFARIN SODIUM 131 127 13 11
ATORVASTATIN CALCIUM 128 114 14 14
METFORMIN HCL 126 113 15 6
GABAPENTIN 122 106 16 13
METOPROLOL TARTRATE 118 104 17 7
TAMSULOSIN HCL 110 110 18 29
DIOVAN 110 105 18 34
FLUTICASONE PROPIONATE 101 95 20 23
TERAZOSIN HCL 83 78 21 61
ALLOPURINOL 82 82 22 33
FUROSEMIDE 78 71 23 9
DONEPEZIL HCL 68 68 24 32
LANTUS 66 66 25 30
FLUOXETINE HCL 62 57 26 49
CITALOPRAM HBR 60 60 27 19
METOPROLOL SUCCINATE 60 60 27 21
RANITIDINE HCL 59 59 29 28
PREDNISONE 59 50 29 43
OXYCODONE HCL 58 19 S2 31 42
LEVOXYL 57 56 32 106
METFORMIN HCL ER 56 45 33 77
FINASTERIDE 55 52 34 59
SERTRALINE HCL 53 52 35 24
OXYCODONE-ACETAMINOPHEN 53 34 S2 35 31
TRAMADOL HCL 53 53 35 25
KLOR-CON 10 50 43 38 88
TRAZODONE HCL 50 46 38 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.